A disruptive technology to tackle brain cancer and glioblastoma
News
Hemerion lève 3,5 millions € pour financer le développement de nouvelles solutions pour le traitement du glioblastome
Un an après la première levée de fonds, le nouveau financement de 3,55 M d’euros obtenu par Hemerion permet d'accélérer la mise en place d’essais cliniques internationaux dans le traitement… ...
May 12. 2017: the first ever patient treated with Hemerion technology
Five years ago, on May, 12th 2017, Pr. Nicolas Reyns delivered, for the first time ever, the therapy currently being developed by Hemerion. It was the first time that this… ...
Hemerion raises €3.5 million to develop new solutions for the treatment of glioblastoma
One year after the first round of funding, Hemerion's new €3.55 million financing will accelerate the implementation of international clinical trials for the treatment of glioblastoma, the most aggressive brain… ...
Stay tuned to our clinical advances